RTP Mobile Logo

Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Myelofibrosis

COCMF13/2

TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses and other practitioners involved in the management of myelofibrosis.

Patterns of Care Data Regarding Ruxolitinib Use in Patients without JAK2 Mutations

Patterns of Care Data Regarding Ruxolitinib Use in Patients without JAK2 Mutations

Additional Commentary

Allotransplant in patients with MF?

In what situations, if any, do you recommend allotransplant to patients with MF?

Additional Commentary

Splenectomy in patients with MF?

Presently, how often do you recommend splenectomy to patients with MF?

Additional Commentary

Other diseases most commonly confused with MF?

Based on your clinical experience, which of the following disease states is most often confused with a diagnosis of myelofibrosis (MF)?

Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Myelofibrosis

COCMF13/1

TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses and other practitioners involved in the management of myelofibrosis.

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Breast Cancer